Docent Institute of Urology Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2009
NCT01231165
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Clinical Research Unit at Docent Institute of Urology | Clinical Research Unit at the Docent Institute of Urology | Clinical Research Unit at the Instituto Docente de Urologia

Active Ingredients

Drugs in Phase 3 Trials (3)

acetylsalicylic acid (aspirin) (1 trial)

amiloride (midamor) (2 trials)

nitric acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Heart Diseases (Phase 3)

Myocardial Ischemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3